Pliant Therapeutics (PLRX) PT Lowered to $43 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.07 -0.93%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $43.00 (from $48.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- AP Moller Maersk (MAERSKB:DC) (AMKBY) PT Raised to DKK20,864 at Citi
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
